Britecyte’s Clinical Study “A Phase 1/2a, Multicenter, Randomized, Controlled, Single-Blind, Dose-Finding Study to Evaluate the Safety and Efficacy of BRC-OA, a Human Adipose Allograft, for Treatment of Knee Osteoarthritis” was awarded a $1,000,000 Clinical Program Grant from the Maryland Stem Cell Research Fund (MSCRF)